Prototype ISO IDMP Compliant Datafeed to eHealth (Deliverable D4.12)
1.0.0 - STU1 International flag

Prototype ISO IDMP Compliant Datafeed to eHealth (Deliverable D4.12), published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/unicom-project-eu/d4.12/ and changes regularly. See the Directory of published versions

Example Bundle: PT-Augmentin-500-125-FilmCoatedTablets

Augmentin 500 mg + 125 mg Comprimido revestido por película

MPID: PT-100002296-709

Full name: Augmentin 500 mg + 125 mg Comprimido revestido por película

Name usage: Portuguese (Portuguese Republic)


Authorised dose form: Film-coated tablet

Legal status of supply: Medicinal Product subject to medical prescription

Domain: Human use

Resource status: Provisional


Product classification:

  • J01CR02 amoxicillin and beta-lactamase inhibitor
  • 100000096162 amoxicillin and beta-lactamase inhibitor

Marketing Authorisation 1 of 1

Authorisation number: 8604702

Region: Portuguese Republic

Marketing authorisation holder: GlaxoSmithkline Produtos Farmacêuticos, Lda.

Identifier:

  • LOC-100002296

Status: Valid ()

Package 1 of 1

PCID: PT-100002296-709-50001639

Description:
Augmentin 500 mg + 125 mg Comprimido revestido por película 16 Comprimido Blister

Marketing status:

  • Portuguese Republic: Marketed

Pack size:

  • 16 Tablet

Package: 1 Box

Containing:

Package: Blister

Containing: 16

Manufactured Item

Dose form: Film-coated tablet

Unit of presentation: Tablet

Ingredient

Role: active

Substance: AMOXICILLIN TRIHYDRATE

Presentation strength: 573.96 milligram(s) / 1 Tablet


Reference strength:
Amoxicillin 500 milligram(s) / 1 Tablet

Ingredient

Role: active

Substance: Potassium clavulanate

Presentation strength: 148.91 milligram(s) / 1 Tablet


Reference strength:
Clavulanic acid 125 milligram(s) / 1 Tablet

Administrable Product (1 of 1)

Dose form: Film-coated tablet

Unit of presentation: Tablet

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: active

Substance: AMOXICILLIN TRIHYDRATE

Presentation strength: 573.96 milligram(s) / 1 Tablet


Reference strength:
Amoxicillin 500 milligram(s) / 1 Tablet

Ingredient

Role: active

Substance: Potassium clavulanate

Presentation strength: 148.91 milligram(s) / 1 Tablet


Reference strength:
Clavulanic acid 125 milligram(s) / 1 Tablet